ARDX FY2025 SEC EDGAR DEF 14A #112 of 168 in industry

Ardelyx, Inc. CEO pay ratio

The CEO earned $7.8M in FY2025 against median worker pay of $311,004 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#112/168

Data updated August 2026

Subscribe to Ardelyx, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
25:1
Below Average (Scale: 0–1000:1)
CEO pay
$7.8M
Median worker
$311,004

Answer first

Ardelyx, Inc.'s FY2025 CEO total of $7.8M ranks #701 of 1,423 complete filings; its 25:1 pay ratio ranks #1167. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $311,004. Industry placement uses the FY2025 SIC-28 peer cohort (# 112 of 168, 34th percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#701
$7.8M of 1,423 FY2025
Ratio rank
#1167
25:1 of 1,423
Industry pct
34th
below the industry median pay ratio

How Ardelyx, Inc. ranks nationally

Ardelyx, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$7,796,171 Top 49% higher than 51% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). This entry sits in this band. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Ardelyx, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($7.8M) against pay ratio (25:1) for Ardelyx, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both33658.62759449.65485240.58211031.410936822.323.1:128.1:133:138.0:142.9:1CEO total payPay ratio (CEO : median worker)Ardelyx, Inc., CEO total pay: 7796171 · Pay ratio (CEO : median worker): 25:1Ardelyx, Inc.Siga Technologies Inc, CEO total pay: 3202425 · Pay ratio (CEO : median worker): 25:1Siga Technologies IncBiohaven Ltd., CEO total pay: 529257 · Pay ratio (CEO : median worker): 25:1Biohaven Ltd.Sarepta Therapeutics, Inc., CEO total pay: 7708375 · Pay ratio (CEO : median worker): 25:1Sarepta Therapeutics, Inc.Vir Biotechnology, Inc., CEO total pay: 7948488 · Pay ratio (CEO : median worker): 24:1Vir Biotechnology, Inc.Mirum Pharmaceuticals, Inc., CEO total pay: 10441224 · Pay ratio (CEO : median worker): 24:1Mirum Pharmaceuticals, Inc.
Ardelyx, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Ardelyx, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Ardelyx, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2024–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
25:1
FY2025
vs prior FY
-15:1
from FY2024 40:1
CEO $ YoY
-19%
$7.8M latest
Filings shown
2
FY2024–2025
Ardelyx, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2024 $9.6M - $239,432 40:1 -
2025 $7.8M -19% $311,004 25:1 -15:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1437402, FY2024–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
25:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$7.8M
Companies in Industry
168
vs. Industry Median
Below
#112 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Ardelyx, Inc.: MODEST · HEAVY pay ratio

Ardelyx, Inc.'s 25:1 ratio ranks #1167 of 1,423 FY2025 complete filings (lower third by ratio). the CEO earned 25× the median employee ($311,004) in FY2025.

Median employee $311,004 (ELITE-MED); MODEST · HEAVY stamps put about 25 median-wage years per CEO year.

CEO Total Pay

$7.8M

FY2025 Summary Compensation, near median

Pay Ratio

25:1

Below typical

Ardelyx, Inc. in the lower-ratio third

Ardelyx, Inc.'s 25:1 ratio ranks #1167 of 1,423 FY2025 complete filings (lower third by ratio). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Ardelyx, Inc.'s $7.8M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #701 and ratio rank #1167 split - treat 25:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$7.8M
Median Employee Pay
$311,004
Pay Ratio
25:1
Filing Date
2026-04-29

Company Info

Ticker
ARDX
CIK
1437402
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1437402, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Ardelyx, Inc.'s 25:1 ratio ranks #1167 of 1,423 FY2025 complete filings (lower third by ratio).

Read with Ardelyx, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

StandardAero, Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.8M (Δ $5K lighter vs Ardelyx, Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Onto Innovation Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.8M (Δ $17K heavier vs Ardelyx, Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Maxlinear, Inc · HEAVY

ABS(ceo_total_comp) peer at $7.8M (Δ $21K heavier vs Ardelyx, Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Kite Realty Group Trust · HEAVY

ABS(ceo_total_comp) peer at $7.8M (Δ $23K heavier vs Ardelyx, Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Siga Technologies Inc (SIC 28 pole)

Siga Technologies Inc stamps MODEST · MID$ nearest in-SIC by ABS(pay_ratio) to Ardelyx, Inc.'s MODEST filing.
National dual ranks · #701/#1167

Ardelyx, Inc.'s FY2025 package sits #701 by CEO dollars and #1167 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Ardelyx, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Ardelyx, Inc. (CIK 1437402), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.